首页|急性ST段抬高型心肌梗死介入治疗无复流现象的研究进展

急性ST段抬高型心肌梗死介入治疗无复流现象的研究进展

扫码查看
急性ST段抬高型心肌梗死(STEMI)是最为凶险的心血管疾病之一。经皮冠状动脉介入手术(PCI)可迅速开通闭塞血管恢复心肌血流灌注,显著降低此类患者的死亡率及改善预后。然而,部分患者在开通闭塞血管后心肌灌注受损仍然存在,即出现冠状动脉内无复流(NR),降低了患者的治疗效果及预后。本文就NR的定义、诊断、相关危险因素、防治措施等进行了回顾,并对新技术进行了展望,旨在加强对STEMI患者PCI术后出现NR的关注。
Research progress of no-reflow phenomenon in interventional treatment of acute ST-segment elevation myocardial infarction
Acute ST-segment elevation myocardial infarction(STEMI)is one of the most dangerous cardiovascular diseases.Percutaneous coronary intervention(PCI)can quickly open the occluded vessels and restore myocardial perfusion,which can significantly reduce the mortality and improve the clinical prognosis of such patients.However,some patients still suffer from impaired myocardial perfusion after opening the occluded vessel,that is,no-reflow(NR)in the coronary artery,which reduces the therapeutic effect and prognosis of patients.This article reviews the definition,diagnosis,related risk factors,prevention and treatment measures of NR,and looks forward to new technologies,aiming to strengthen the attention to NR after PCI in STEMI patients.

acute ST-segment elevation myocardial infarctionpercutaneous coronary interventionno-reflowpredictive factor

麦迪娜·卡热、王钊、迪力亚尔·阿地里

展开 >

新疆医科大学,新疆 乌鲁木齐,830000

新疆维吾尔自治区人民医院心血管内科,新疆 乌鲁木齐, 830001

急性ST段抬高型心肌梗死 经皮冠状动脉介入手术 无复流 预测因素

新疆维吾尔自治区人民医院院内项目

20230121

2024

临床医学研究与实践

临床医学研究与实践

ISSN:
年,卷(期):2024.9(11)
  • 26